Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HBD |
| Upstream (Parents) |
|---|
| (<<) HBG2///HBG1 → HBD |
| (<<) HBB → HBD |
| (<<) HBA2///HBA1 → HBD |
| (<<) ALAS2 → HBD |
| (<<) SULF1 → HBD |
| (<<) S100A12 → HBD |
| (<<) COL6A3 → HBD |
| (<<) EPB42 → HBD |
| (<<) CXCR2 → HBD |
| Downstream (Children) |
|---|
| HBD → HBG2///HBG1 (>>) |
| HBD → HBB (>>) |
| HBD → HBA2///HBA1 (>>) |
| HBD → ALAS2 (>>) |
| HBD → FPR1 (>>) |
| HBD → CCDC40 (>>) |
| HBD → HBQ1 (>>) |
| HBD → GABRG3 (>>) |
| HBD → CHAT (>>) |
| HBD → OR1D2 (>>) |
| HBD → TAS2R1 (>>) |
| HBD → CDH10 (>>) |
| HBD → SLC4A1 (>>) |
| HBD → RBP3 (>>) |
| HBD → ZNF442 (>>) |
| HBD → SCUBE3 (>>) |
| HBD → RPGRIP1 (>>) |
